Myrbetriq: Understanding Muscle Pain As A Side Effect

does myrbetriq cause muscle pain

Myrbetriq is a drug used to treat overactive bladder (OAB) and neurogenic detrusor overactivity (NDO). It works by relaxing the muscles in the bladder, increasing the amount of urine the bladder can hold. While Myrbetriq is effective in treating these conditions, it can cause several side effects, including increased blood pressure, headaches, UTIs, and allergic reactions. Some users have also reported muscle pain, specifically in the lower belly or abdomen. This may be related to the drug's impact on bladder muscles and the resulting difficulty in fully emptying the bladder. If you experience any side effects while taking Myrbetriq, it is important to consult your healthcare provider for advice and to ensure the benefits outweigh the risks.

Characteristics Values
Does Myrbetriq cause muscle pain? No evidence found
Myrbetriq side effects Increased blood pressure, headaches, UTIs, dizziness, nausea, diarrhea, constipation, abdominal pain, bladder pain, cystitis, vaginal infection, vulvovaginal pruritus, allergic reactions
Myrbetriq interactions Should not be taken with alcohol or tobacco. May increase blood pressure.
Myrbetriq precautions Should not be taken if you have kidney or liver problems. Should not be taken by children without a prescription.

cyvigor

Myrbetriq may increase blood pressure

Myrbetriq is a prescription medication used to treat an overactive bladder (OAB) and neurogenic detrusor overactivity (NDO). It works by relaxing the muscles in the bladder, increasing the amount of urine the bladder can hold, and preventing incontinence.

It is also important to be aware that Myrbetriq may increase your risk of urinary retention, especially if you are taking other medications such as solifenacin succinate. Urinary retention can cause symptoms such as decreased urine volume, decreased frequency of urination, dribbling, and painful urination. If you experience any of these symptoms, you should consult your doctor.

Other common side effects of Myrbetriq include headaches, UTIs, and dry mouth. These side effects are typically mild and may go away on their own or with over-the-counter treatments. However, it is important to consult your healthcare provider if you have any concerns or if your symptoms persist or become severe.

cyvigor

It can cause allergic reactions

Myrbetriq is a medication used to treat an overactive bladder (OAB) and neurogenic detrusor overactivity (NDO). It works by relaxing the muscles in the bladder, increasing the amount of urine the bladder can hold, and preventing incontinence.

While Myrbetriq is a useful medication for many, it can cause allergic reactions in some people. These allergic reactions can be serious and even life-threatening, so it is important to be aware of the symptoms and act quickly if they occur.

One such allergic reaction is angioedema, which causes large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or genitals. This reaction can also lead to trouble breathing or swallowing, which requires immediate medical attention. If you experience any of these symptoms, stop taking Myrbetriq and seek medical help right away.

Additionally, people with kidney or liver problems should not take Myrbetriq, as it can further compromise the function of these organs. It is important to discuss any health conditions and medications you are taking with your doctor before starting Myrbetriq to ensure it is safe for you.

While rare, serious side effects from Myrbetriq are possible. If you experience any adverse reactions or persistent symptoms, it is important to consult your doctor or pharmacist for advice and to determine if Myrbetriq is the right medication for you.

cyvigor

It can cause urinary retention

Myrbetriq is a medication used to treat urinary incontinence, a symptom of overactive bladder (OAB). It works by relaxing the muscles in the bladder, helping the bladder to store more urine and thereby reducing incontinence. However, this mechanism of action can sometimes lead to urinary retention—trouble passing urine or fully emptying the bladder.

Urinary retention occurs when there is a blockage that reduces or stops the flow of urine out of the bladder. An enlarged prostate is an example of a bladder outlet obstruction. Taking certain other medications, such as solifenacin (Vesicare) or muscarinic antagonists, can also increase the risk of urinary retention in patients taking Myrbetriq.

Urinary retention can cause serious complications if left untreated. The buildup of urine in the bladder can increase pressure in the urinary tract, potentially damaging the kidneys. Therefore, it is important to seek medical attention if you experience symptoms of urinary retention, such as decreased urine volume, decreased frequency of urination, difficulty passing urine (dribbling), or painful urination.

The risk of urinary retention with Myrbetriq treatment should be carefully considered by both patients and their doctors. While it is not a common side effect, it can occur, especially in individuals with bladder outlet obstruction or those taking certain concomitant medications. Patients experiencing symptoms suggestive of urinary retention should promptly consult their healthcare provider to determine the most appropriate course of action.

In summary, Myrbetriq can cause urinary retention by relaxing the bladder muscles, making it difficult for the bladder to contract and fully empty. This side effect may be more likely in individuals with bladder obstructions or those taking certain other medications. Urinary retention can have serious consequences, so it is important to monitor for symptoms and seek medical advice if necessary.

cyvigor

It can lead to UTIs

Myrbetriq is a prescription drug used to treat certain bladder conditions in adults and some children. It is used to treat symptoms of an overactive bladder (OAB), such as incontinence (loss of bladder control), a strong need to urinate right away, or a frequent need to urinate. It is also used to treat neurogenic detrusor overactivity (NDO).

Myrbetriq works by relaxing the muscles in the bladder to increase the amount of urine the bladder can hold and prevent incontinence. However, this can sometimes make it difficult for the bladder to contract enough to fully empty when urinating (urinary retention). Urinary retention can increase the pressure in the urinary tract and damage the kidneys if left untreated.

Myrbetriq has been associated with an increased risk of urinary tract infections (UTIs). UTIs were a reported side effect in clinical studies, and it was one of the most common side effects. However, a recent review found that taking Myrbetriq does not seem to increase the risk of UTIs. Nonetheless, it is important to be able to recognize the symptoms of a UTI, as prompt treatment can help lower the risk of the infection spreading to the kidneys.

Symptoms of a UTI include a frequent urge to urinate, pain when urinating, new or abnormal pain in the lower belly, and worsening OAB symptoms. If you experience these symptoms, it is important to contact your doctor, who may recommend testing your urine for bacteria to confirm the presence of an infection. Treatment for UTIs typically involves the use of antibiotics.

To help prevent UTIs while taking Myrbetriq, it is recommended to drink plenty of water, as this will increase urination and flush bacteria out of the urinary tract. Other preventive measures include wiping from front to back after using the bathroom, urinating before and after sex, and considering the use of the dietary supplement D-mannose, which may help prevent UTIs.

cyvigor

It may cause headaches

Myrbetriq is a medication used to treat overactive bladder (OAB) and neurogenic detrusor overactivity (NDO). It works by relaxing the muscles in the bladder, increasing the amount of urine the bladder can hold and preventing incontinence.

Like any medication, Myrbetriq can cause side effects, and one of the most common is headaches. However, it is important to note that headaches were just as common in the placebo group during clinical studies. Dehydration is a common cause of headaches, and this may be the reason for their occurrence in some patients taking Myrbetriq.

If you experience a headache while taking Myrbetriq, it is important to stay hydrated and monitor your symptoms. In most cases, headaches will go away on their own without any intervention. However, if the headache persists or becomes severe, it is recommended to contact your healthcare provider. They can help determine if the headache is related to the medication or another cause and suggest appropriate treatment options if needed.

Over-the-counter pain relievers, such as Tylenol (acetaminophen) or Advil (ibuprofen), can help alleviate headache pain with the approval of your healthcare provider. It is important to consult your doctor or pharmacist before taking any new medications, including over-the-counter remedies, to ensure they are safe to use in conjunction with Myrbetriq.

While Myrbetriq may cause headaches in some individuals, it is important to weigh the benefits of the medication against the potential side effects. For many patients, the relief from OAB and NDO symptoms outweighs the risk of experiencing mild to moderate side effects. Always consult your healthcare provider if you have any concerns or questions about your medication and its potential side effects.

Frequently asked questions

Myrbetriq is a drug used to treat an overactive bladder (OAB) and neurogenic detrusor overactivity (NDO). It works by relaxing the muscles in the bladder. While muscle pain is not listed as a side effect, Myrbetriq may cause urinary retention (trouble passing urine or not fully emptying the bladder).

The most common side effects of Myrbetriq are increased blood pressure, headaches, UTIs, dry mouth, and constipation.

Yes, serious allergic reactions and angioedema (swelling of the lips, face, tongue, or throat) are possible side effects of Myrbetriq. If you experience these symptoms, seek immediate medical attention.

Written by
Reviewed by
Share this post
Print
Did this article help you?

Leave a comment